After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology......
No paracetamol or painkiller is recommended after being vaccinated with COVID-19 vaccine Covaxin, Bharat Biotech said on Wednesday. "We have received feedback that certain immunisation......
Brazil has suspended the clinical studies of Bharat Biotech's COVID-19 vaccine, Covaxin following termination of the company's agreement with its partner there, the South American Country's......
Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme. ......
The supply price of Bharat Biotech's COVID-19 vaccine Covaxin to the central government at Rs 150 per dose is not sustainable in the long run, the vaccine maker said on Tuesday. The Centre's......
Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed. Hyderabad based Bharat Biotech, whose Covid-19 vaccine......
The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech ......
ONGC was the top gainer in the Sensex pack, rising around 4 per cent, followed by TCS, HCL Tech, Tech Mahindra, Infosys, M&M, HUL and L&T. On the other hand, Kotak Bank, Bajaj Finance, Asian......
'Since there are very few months left for the Games and the safety of the participants are utmost important so to ensure all of them are vaccinated for COVID-19 prior to travel to Tokyo.' IMAGE:......